Vaishali Pharma Q3 Results
- BSE: -
- NSE: VAISHALI
- ISIN: INE972X01022
- Sector: Biotechnology & Drugs
BSE
This stock is not traded on BSE
NSE
7.50
0.95 (14.50%)
0.95 (14.50%)Volume1.43 M
Updated: Fri 17 Apr, 2026 | 15:29:56
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
- Total Income₹24.65 Cr.(-11.69%)
- Operating Profit₹1.43 Cr.(15.16%)
- Profit After Tax₹1.32 Cr.(-8.63%)
- Operating Margin5.81%(30.40%)
Note: Comparison is on YoY basis
Quarterly - Vaishali Pharma Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 23.22 | 18.49 | -27.95% | 25.07 | -12.94% |
| Depreciation/ Amortization | 0.13 | 0.12 | -26.42% | 0.12 | 4.02% |
| Operating Income | 1.43 | 2.30 | 17.64% | 2.83 | 15.16% |
| Net Income | 1.32 | 1.97 | 11.26% | 2.11 | -8.63% |
| Other Operating Expenses Total | 1.43 | 0.94 | -17.07% | 0.45 | -34.34% |
| Net Income Before Taxes | 1.83 | 2.63 | 10.67% | 2.86 | -4.91% |
| Total Revenue | 24.65 | 20.79 | -26.29% | 27.90 | -11.69% |
| Selling/ General/ Admin Expenses Total | 0.72 | 0.62 | 14.39% | 0.56 | 14.59% |
| Diluted Normalized EPS | 0.10 | 0.15 | -79.59% | 0.19 | -9.57% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.